Preparing for tirzepatide treatment: the decisions that matter most

The misconception about 'getting ready', and what actually counts

A lot of people approach tirzepatide preparation as though it means starting a strict diet the week before, as if arriving at the first injection with a perfect eating record gives the medicine a head start. It doesn't work that way. The medicine works by changing appetite signalling at the receptor level, not by adding to willpower. What genuinely helps is building habits that will hold when nausea is mild or tiredness dips your motivation in week two.

That means three practical things before your first dose. First, identify two or three meals that are high in protein, easy to digest, and small enough to eat when hunger is blunted. The NHS tirzepatide information page highlights that eating smaller portions is one of the main behavioural shifts people notice early on, working out in advance what 'smaller' looks like for you removes a decision from a day when you already feel nauseous. Second, plan your injection day and time; once-weekly consistency matters, and picking a day that is reliably low-pressure (not the morning of a long work trip) reduces accidental delays. Third, confirm your fridge situation. The pen must be kept between 2°C and 8°C, and the exact room-temperature window for short excursions is set out in the Patient Information Leaflet, check it before you travel.

Strength-based activity is worth starting before treatment too, not cardio for the sake of burning calories but resistance work that protects muscle while weight falls. Your prescriber or a dietitian is the right person to advise on volume and timing.

Medicines and contraceptives: conversations to have before day one

Tirzepatide slows gastric emptying, which affects how quickly other oral medicines are absorbed. This is relevant to a short but important list of drugs, and your prescriber needs your full medication record before you start, not just your repeat prescriptions but any over-the-counter medicines you take regularly.

The most time-sensitive issue is oral contraception. For the first four weeks of tirzepatide and for four weeks after each dose increase, NHS guidance recommends adding a non-oral method of contraception (such as condoms) because absorption of the pill may be reduced during those periods. NHS England's guidance on weight-management injections also advises considering transdermal HRT (patches or gels) during tirzepatide treatment for the same absorption reason. If you use HRT, raise this with your prescriber before your first dose so any switch is planned rather than reactive.

If you are taking any medicine with a narrow therapeutic window (thyroid replacement, anticoagulants, anticonvulsants) your prescriber may want to monitor levels more closely in the early months. Bring every packet to the consultation, or list them in full. This is not a formality; it is a genuine clinical step.

Pregnancy, breastfeeding, and trying to conceive are all situations where tirzepatide is not recommended. Discuss contraception plans explicitly with your prescriber if any of these are relevant to your circumstances.

Eligibility, timing, and setting realistic expectations

Tirzepatide is licensed for adults with a BMI of 30 or above, or 27 and above alongside at least one weight-related condition such as high blood pressure, type 2 diabetes, high cholesterol, or obstructive sleep apnoea. Lower BMI thresholds apply for some ethnic backgrounds under UK guidance. A BMI figure alone does not determine approval; the prescriber assesses the full clinical picture, including your medication history and any contraindications.

The NICE appraisal of tirzepatide sets additional criteria for NHS access (stricter than the licensed indication) but private treatment through a regulated pharmacy follows the licence directly, without referral or a waiting list, subject to that clinical assessment. If you want to understand the cost context for private treatment, our guide on Mounjaro pricing in the UK sets out what private prescriptions typically include and what to look for when comparing providers.

The starting dose of 2.5 mg is not a therapeutic dose in the sense that meaningful weight change usually comes at higher doses after titration. In SURMOUNT-1, a large randomised trial published in the New England Journal of Medicine, participants on 15 mg tirzepatide achieved around 20–21% average body-weight reduction over 72 weeks. That outcome takes months of titration. Preparation means accepting that the early weeks are an adjustment period, not a results period, and planning accordingly so you are not discouraged and do not stop too soon. If you want to understand how tirzepatide's duration of action shapes the weekly dosing schedule and what that means in practice, that detail is worth reading before your first injection. You can also find a broader overview of the treatment in our tirzepatide guide, which covers the key stages from starting dose through to maintenance.

Practical steps for the day your pen arrives

When your pen arrives from a GPhC-registered pharmacy, the first task is straightforward: it goes into the fridge, between 2°C and 8°C, away from the freezer compartment. Read the Patient Information Leaflet that day, not on injection morning. It covers the exact steps for administering the dose, rotating injection sites (abdomen, thigh, upper arm), what to do if a dose is missed, and the room-temperature storage limits for brief excursions, details your prescriber and the leaflet handle far better than any content page can.

If you notice the pen has been exposed to temperatures outside the recommended range during delivery, check the guidance on tirzepatide storage and expiry before using it. Inject at roughly the same time each week; the day matters more than the hour. Rotate sites methodically, the same spot repeatedly can cause localised reactions that slow absorption.

The first injection is often the thing people worry about most. The KwikPen is designed so the needle is not visible during use, and the mechanism is straightforward to follow from the leaflet. If you have genuine concerns about technique, your prescriber or aftercare team can walk you through it. That is what clinical aftercare is for, and at nume it is available seven days a week.